Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 6 August

Paulina Peters
August 6, 2020

Morning Bell 5 August

Geoff Beeston
August 5, 2020

Morning Bell 4 August

Jessica Amir
August 4, 2020

Morning Bell 3 August

Jessica Amir
August 3, 2020

Monthly Wrap July 2020

Jessica Amir
July 31, 2020

Morning Bell 31 July

Jessica Amir
July 31, 2020

Morning Bell 30 July

Jessica Amir
July 30, 2020

Morning Bell 29 July

Jessica Amir
July 29, 2020

How to use ETFs in your portfolio

Bell Direct
July 28, 2020

Morning Bell 28 July

Jessica Amir
July 28, 2020

Morning Bell 27 July

Jessica Amir
July 27, 2020